>

Janssen Pharmaceutical Companies

  • Close-up medical syringe drawing medication from a vial

    VUMC begins study of second COVID-19 vaccine

    Vanderbilt University Medical Center has begun recruiting up to 250 participants for a Phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. Read More

    Nov 2, 2020